Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Canals

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Oncotarget|March 20, 2015
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancerÓscar Aguilera, José Manuel González-Sancho, Sandra Zazo, et al.
Cell Death and Differentiation|October 2, 2019
Targeting PML in triple negative breast cancer elicits growth suppression and senescenceLeire Arreal, Marco Piva, Sonia Fernández, et al.
The FEBS Journal|March 7, 2024
LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cellsGemma Serra-Bardenys, Enrique Blanco, Carmen Escudero-Iriarte, et al.
Journal of Proteome Research|October 22, 2013
Surfing transcriptomic landscapes. A step beyond the annotation of chromosome 16 proteomeVíctor Segura, Juan Alberto Medina-Aunon, Maria I Mora, et al.
Journal of Proteomics|November 10, 2021
Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysisNúria Colomé, Joaquín Abian, Kerman Aloria, et al.
Journal of Proteomics|December 20, 2016
A multicentric study to evaluate the use of relative retention times in targeted proteomicsVital Vialas, Núria Colomé-Calls, Joaquín Abian, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Oncotarget|March 20, 2015
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancerÓscar Aguilera, José Manuel González-Sancho, Sandra Zazo, et al.
Cell Death and Differentiation|October 2, 2019
Targeting PML in triple negative breast cancer elicits growth suppression and senescenceLeire Arreal, Marco Piva, Sonia Fernández, et al.
The FEBS Journal|March 7, 2024
LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cellsGemma Serra-Bardenys, Enrique Blanco, Carmen Escudero-Iriarte, et al.
Journal of Proteome Research|October 22, 2013
Surfing transcriptomic landscapes. A step beyond the annotation of chromosome 16 proteomeVíctor Segura, Juan Alberto Medina-Aunon, Maria I Mora, et al.
Journal of Proteomics|November 10, 2021
Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysisNúria Colomé, Joaquín Abian, Kerman Aloria, et al.
Journal of Proteomics|December 20, 2016
A multicentric study to evaluate the use of relative retention times in targeted proteomicsVital Vialas, Núria Colomé-Calls, Joaquín Abian, et al.
Pageof 8